Clinical Trial Detail

NCT ID NCT02419495
Title Selinexor in Combination With Standard Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Cyclophosphamide

Pemetrexed Disodium

Eribulin

Selinexor

Carboplatin

Paclitaxel

Topotecan

Dexamethasone

Doxorubicin

Age Groups: adult

No variant requirements are available.